Conflict of interest statement: Compliance with ethical standardsNot applicable. The authors declare that they have no conflict of interest.Patients have not beeninvolved in the study.No experiments have been performed including patientsand/or animals.18. Ecancermedicalscience. 2018 Feb 14;12:811. doi: 10.3332/ecancer.2018.811.eCollection 2018.Palliative hysterectomy for vaginal bleeding from breast cancer metastatic to theuterus.Berger AA(1), Matrai CE(2), Cigler T(2), Frey MK(2).Author information: (1)Hadassah-Hebrew University School of Medicine, Faculty of Medicine, The HebrewUniversity of Jerusalem, Ein Kerem, PO Box 12271, Jerusalem, 9112102, Israel.(2)Weill Cornell Medicine, New York, NY 10065, USA.Breast cancer is the most prevalent cancer in the United States. With anincreasing rate of survivorship and extended life span for patients withmetastatic disease, the demand for palliative care is increasing. Althoughuncommon, metastases to gynaecologic organs have been reported and are oftenpresent with post-menopausal bleeding. Post-menopausal bleeding can becomeclinically significant and have a detrimental effect on quality of life. Wereport the case of a 70-year-old woman with symptomatic vaginal bleeding causedby breast cancer metastatic to her uterus, cervix, fallopian tubes and ovaries.She was successfully treated with minimally invasive hysterectomy, resolving her vaginal bleeding and anemia and allowing her to resume chemotherapy.DOI: 10.3332/ecancer.2018.811 PMCID: PMC5834314PMID: 29515652 